Vactosertib potently improves anti-tumor properties of 5-FU for colon cancer

被引：0
|
作者：
Maryam Moradi Binabaj
Fereshteh Asgharzadeh
Farzad Rahmani
Abdulridha Mohammed Al-Asady
Milad Hashemzehi
Atena Soleimani
Amir Avan
Saeedeh Mehraban
Elnaz Ghorbani
Mikhail Ryzhikov
Majid Khazaei
Seyed Mahdi Hassanian
机构：
[1] Sabzevar University of Medical Sciences,Cellular and Molecular Research Center
[2] Mashhad University of Medical Sciences,Department of Clinical Biochemistry, Faculty of Medicine
[3] Mashhad University of Medical Sciences,Department of Physiology, Faculty of Medicine
[4] Mashhad University of Medical Sciences,Kashmar School of Nursing
[5] University of Warith Al-Anbiyaa,Department of Medical Sciences, Faculty of Nursing
[6] Mashhad University of Medical Sciences,Department of Pharmacology, Faculty of Medicine
[7] University of Kerbala,Department of Medical Sciences, Faculty of Dentistry
[8] Iranshahr University of Medical Sciences,Department of Human Genetics, Faculty of Medicine
[9] Mashhad University of Medical Sciences,Metabolic Syndrome Research Center
[10] Mashhad University of Medical Sciences,Immunology Research Center, Inflammation and Inflammatory Diseases Division, School of Medicine
[11] Mashhad University of Medical Sciences,Department of Medical Microbiology and Virology, Faculty of Medicine
[12] Mashhad University of Medical Sciences,School of Medicine
[13] Saint Louis University,undefined
来源：
DARU Journal of Pharmaceutical Sciences | 2023年 / 31卷 / 2期
关键词：
TGFβ receptor I inhibitor; Vactosertib; EW-7197; 5-FU; Colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：193 / 203
页数：10
相关论文
共 50 条
  • [21] Preclinical anti-tumor activity of nanoliposomal irinotecan (Nal-IRI, MM-398) 5-FU + oxaliplatin in pancreatic cancer
    Gaddy, Daniel F.
    Lee, Helen
    Paz, Nancy
    Leonard, Shannon C.
    Kalra, Ashish
    Straubinger, Ninfa L.
    Straubinger, Robert M.
    Gillard, Bryan M.
    Moser, Michael T.
    Drummond, Daryl C.
    Klinz, Stephan G.
    Hendriks, Bart S.
    Fitzgerald, Jonathan B.
    CANCER RESEARCH, 2016, 76
  • [22] Effect of Grifola frondosa polysaccharide on anti-tumor activity in combination with 5-Fu in Heps-bearing mice
    Mao, Guang-Hua
    Zhang, Zhe-Han
    Fei, Fan
    Ding, Yang-Yang
    Zhang, Wei-Jie
    Chen, Hui
    Ali, Sameh Samir
    Zhao, Ting
    Feng, Wei-Wei
    Wu, Xiang-Yang
    Yang, Liu-Qing
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2019, 121 : 930 - 935
  • [23] TREATMENT OF METASTATIC COLON CANCER WITH 5-FU, MECCNU, BCG AND LEUCOVORIN
    TISMAN, G
    WU, SJ
    HITTLE, T
    STEVENS, T
    FOX, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 217 - 217
  • [24] STUDIES OF THE ANTI-TUMOR ACTION OF 5-FLUOROURACIL (FU)
    MANDEL, HG
    KLUBES, P
    FERNANDES, DJ
    BULLETIN DU CANCER, 1979, 66 (01) : 49 - 54
  • [25] 5-FU for cervical cancer
    不详
    AIDS PATIENT CARE AND STDS, 2000, 14 (03) : 173 - 173
  • [26] Resveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosis
    Dun, Jiening
    Chen, Xueyan
    Gao, Haixia
    Zhang, Yan
    Zhang, Huajun
    Zhang, Yongjian
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 240 (12) : 1672 - 1681
  • [27] Rhein Lysinate Induced S-Phase Arrest and Increased the Anti-Tumor Activity of 5-FU in HeLa Cells
    Lin, Ya-Jun
    Zhen, Yong-Zhan
    Zhao, Yu-Fang
    Wei, Jie
    Hu, Gang
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2011, 39 (04): : 817 - 825
  • [28] 5-Fluorouracil (5-FU) plus leucovorin versus 5-FU leucovorin plus interferon-A given as adjuvant chemotherapy in colon cancer
    Papacostas, P
    Stathopoulos, GP
    Malamos, NA
    Michailakis, E
    Rigatos, S
    Golematis, B
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 752 - 752
  • [29] Rutin enhances the antiproliferative effect of 5-FU and oxaliplatin in colon cancer cells
    Nasiri, Farnoud
    Kismali, Gorkem
    Alpay, Merve
    Kosova, Funda
    Cakir, Dilek Ulker
    Sel, Tevhide
    CANCER RESEARCH, 2016, 76
  • [30] ANXA1 is involved in resistance to 5-FU in colon cancer cells
    Saito, Motonobu
    Onozawa, Hisashi
    Sakuyama, Misato
    Ashizawa, Mai
    Kikuchi, Tomohiro
    Okayama, Hirokazu
    Endo, Hisahito
    Fujita, Shotaro
    Sakamoto, Wataru
    Saze, Zenichiro
    Momma, Tomoyuki
    Ohki, Shinji
    Kono, Koji
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
12345